Vfend Tablet, Film Coated
NDC Package 0049-3170-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vfend (voriconazole) tablets is voriconazole is used to treat a variety of fungal infections. This formulation utilizes a tablet, film coated delivery system. Marketed by Roerig, this product is identified by NDC 0049-3170 and is authorized under FDA application NDA021266.

Identification & Billing

NDC Package Code
0049-3170-30
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
0049-3170
11-Digit Billing Format
00049317030
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vfend
Non-Proprietary Name
Voriconazole
Substance Name
Voriconazole
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
VORICONAZOLE 50 mg/1
Pharmacologic Class
Usage Information
Voriconazole is used to treat a variety of fungal infections. It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.

Regulatory & Marketing

Labeler Name
Roerig
Product Type
Human Prescription Drug
FDA Application #
NDA021266
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-28-2003
End Marketing Date
06-30-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0049-3170-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Vfend, a human prescription drug labeled by Roerig. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet, film coated is formulated for oral use and contains voriconazole as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Roerig on March 28, 2003.

What are the primary indications for this medication?

Voriconazole is used to treat a variety of fungal infections. It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.

How is this Roerig product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00049317030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0049-3170-30
11-Digit CMS (5-4-2)
00049-3170-30

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.